English
Home > Products > CAS:1778-02-5

China CAS:1778-02-5 Manufacturer

Sticking to the principle of "Super Good quality, Satisfactory service" ,We are striving to become an excellent organization partner of you for CAS:1778-02-5,Pregnenolone, Our goal is always to enable clients comprehend their plans. We have been creating good endeavours to accomplish this win-win scenario and sincerely welcome you to join us.
CAS:1778-02-5, We severely promise that we give all the customers with the best quality products and solutions, the most competitive prices and the most prompt delivery. We hope to win a resplendent future for customers and ourselves.

Related Products

Hot Products

  • Dutasteride

    Dutasteride

    Dutasteride has EP, USP, CP, IP, JP specification. CEP and FDA available.

    CAS:164656-23-9

  • Estradiol Hemihydrate

    Estradiol Hemihydrate

    Estradiol Hemihydrate has USP and EP specification. DMF available.

    CAS:50-28-2

  • Estriol

    Estriol

    Estriol has CP, EP, USP specifications. DMF under filing.

    CAS:50-27-1

  • Dienogest

    Dienogest

    Dienogest has EP specifications. DMF approved.

    CAS:65928-58-7

  • Megestrol Acetate

    Megestrol Acetate

    Megestrol acetate has CP, EP and USP specifications. DMF under filing.

    CAS:595-33-5

  • Lasmiditan Succinate

    Lasmiditan Succinate

    Lasmiditan Succinate has In-house specification. DMF approved.

    CAS:439239-92-6

  • Related Blog
  • Reviews

  • 2021 API Exhibition Wuhan

    October 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • 2023 See us at DCAT Week, CPHI and API exhibition!

  • 2024 VIETNAM MEDI-PHARM EXPO

    VIETNAM MEDI-PHARM EXPO 2024 will be held at Saigon Exhibition & Convention Center – SECC from August 1 to 3, our booth number is I19.

  • Welcome to Xi'an API 2024

    The 91th API China & PHARMEX & PHARMPACK & SINOPHEX will be held at National Exhibition and Convention Center (Xi’an) from October 16 to 18, our booth number is 3A08.

  • Is Dutasteride the Most Effective Solution for Hair Loss and Benign Prostatic Hyperplasia

    As a trusted pharmaceutical manufacturer, Humanwell has continuously focused on providing high-quality active pharmaceutical ingredients and healthcare solutions. Among these, Dutasteride has gained significant attention worldwide due to its proven effectiveness in treating benign prostatic hyperplasia (BPH) and its growing application in hair loss management. As more healthcare professionals and consumers seek reliable solutions, understanding how Dutasteride works, its benefits, safety profile, and potential applications becomes increasingly important.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept